Helsinki, Finland

Mikko Passiniemi

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Mikko Passiniemi and His Contributions to Medicine

Introduction: Mikko Passiniemi, a notable inventor based in Helsinki, Finland, has made significant strides in the field of medicinal chemistry. With a total of four patents to his name, Mikko’s work focuses on innovative compounds that hold promise for therapeutic applications.

Latest Patents: Among his latest patents are groundbreaking discoveries regarding Pyran derivatives identified as inhibitors of CYP11A1 (cytochrome P450 monooxygenase 11A1). These compounds, represented by the formula (I), demonstrate potential in advancing treatment options for various medical conditions.

Career Highlights: Mikko currently works for Orion Corporation, a leading pharmaceutical company known for its commitment to innovation and research in health. His career has been marked by a dedicated approach to developing new therapeutic solutions that can impact patient care positively.

Collaborations: Throughout his career, Mikko has collaborated with fellow researchers and experts, including Pekka Pietikäinen and Petteri Rummakko. These partnerships have enhanced the scope of his work and contributed to the advancement of projects aimed at improving healthcare outcomes.

Conclusion: Mikko Passiniemi’s contributions to the field of medicinal chemistry, exemplified by his patented innovations, showcase the vital role of inventors in shaping the future of medicine. His ongoing work with Orion Corporation continues to inspire advancements in pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…